Austar Lifesciences Limited - Laporan Laba Rugi (TTM)

Austar Lifesciences Limited
HK ˙ SEHK ˙ KYG0632L1023
HK$ 1.21 ↑0.07 (6.14%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Austar Lifesciences Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 1,193 1,296 1,465 1,633 1,824 2,015 2,139 2,264 2,246 2,157 2,065 1,972 1,764 1,654 1,545 1,523 1,500 1,481 1,461
Change (%) 8.67 13.02 11.52 11.68 10.46 6.17 5.81 -0.77 -3.97 -4.28 -4.47 -10.58 -6.20 -6.60 -1.45 -1.47 -1.30 -1.32
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 883 972 1,098 1,223 1,380 1,536 1,655 1,773 1,770 1,668 1,600 1,532 1,428 1,339 1,251 1,225 1,199 1,183 1,166
Change (%) 10.10 12.90 11.43 12.78 11.33 7.72 7.17 -0.20 -5.74 -4.07 -4.24 -6.83 -6.20 -6.61 -2.06 -2.10 -1.37 -1.38
% of Revenue 74.06 75.04 74.96 74.90 75.63 76.23 77.34 78.33 78.78 77.34 77.51 77.69 80.95 80.94 80.94 80.44 79.92 79.87 79.82
Gross Operating Profit 309 324 367 410 444 479 485 490 477 489 464 440 336 315 295 298 301 298 295
Change (%) 4.59 13.36 11.79 8.42 7.76 1.19 1.18 -2.83 2.57 -4.99 -5.25 -23.62 -6.18 -6.58 1.13 1.12 -1.04 -1.05
% of Revenue 25.94 24.96 25.04 25.10 24.37 23.77 22.66 21.67 21.22 22.66 22.49 22.31 19.05 19.06 19.06 19.56 20.08 20.13 20.18
SG&A 253 259 281 304 304 304 304 304 307 303 316 329 333 301 268 253 239 238 237
Change (%) 2.66 8.53 7.86 0.09 0.09 -0.02 -0.02 1.02 -1.38 4.26 4.09 1.37 -9.75 -10.81 -5.45 -5.77 -0.43 -0.43
% of Revenue 21.18 20.01 19.21 18.58 16.65 15.09 14.21 13.43 13.67 14.04 15.29 16.66 18.89 18.17 17.35 16.65 15.92 16.06 16.21
R&D 47 48 50 52 59 66 69 72 71 70 67 64 55 53 51 52 54 50 47
Change (%) 3.47 4.34 4.16 12.52 11.13 5.03 4.78 -1.40 -1.42 -4.18 -4.36 -13.94 -3.61 -3.75 2.16 2.11 -6.52 -6.98
% of Revenue 3.91 3.72 3.44 3.21 3.24 3.26 3.22 3.19 3.17 3.25 3.26 3.26 3.14 3.22 3.32 3.44 3.57 3.38 3.19
OpEx 1,172 1,270 1,420 1,571 1,734 1,898 2,021 2,143 2,141 2,034 1,974 1,914 1,805 1,680 1,554 1,510 1,466 1,446 1,426
Change (%) 8.32 11.86 10.60 10.42 9.44 6.46 6.07 -0.12 -4.98 -2.94 -3.03 -5.71 -6.94 -7.46 -2.86 -2.94 -1.36 -1.38
% of Revenue 98.28 97.96 96.96 96.16 95.08 94.20 94.45 94.69 95.31 94.31 95.62 97.06 102.34 101.52 100.60 99.16 97.68 97.62 97.56
Operating Income 21 26 45 63 90 117 119 120 105 123 90 58 -41 -25 -9 13 35 35 36
Change (%) 28.33 68.79 40.76 43.31 30.22 1.43 1.41 -12.43 16.55 -26.37 -35.82 -171.03 -38.81 -63.43 -238.54 172.18 1.19 1.18
% of Revenue 1.72 2.04 3.04 3.84 4.92 5.80 5.55 5.31 4.69 5.69 4.38 2.94 -2.34 -1.52 -0.60 0.84 2.32 2.38 2.44
Interest Expense -3 -3 -3 -4 -4 -4 -5 -6 -8 -10 -11 -13 -14 -15 -16 -17 -17 -16 -14
Change (%) -2.78 14.39 12.58 11.19 10.06 19.79 16.52 33.39 17.06 17.71 15.05 7.45 8.39 7.74 2.18 2.13 -7.50 -8.10
% of Revenue -0.24 -0.22 -0.22 -0.22 -0.22 -0.22 -0.25 -0.27 -0.36 -0.44 -0.55 -0.66 -0.79 -0.91 -1.06 -1.09 -1.13 -1.06 -0.99
Net Income 25 33 136 238 258 277 191 105 96 87 45 2 -113 -91 -68 -26 16 26 35
Change (%) 32.92 309.80 75.60 8.21 7.59 -31.02 -44.97 -8.46 -9.24 -49.04 -96.24 -6,878.55 -20.19 -25.30 -61.88 -162.35 59.46 37.29
% of Revenue 2.09 2.55 9.26 14.58 14.13 13.76 8.94 4.65 4.29 4.05 2.16 0.08 -6.43 -5.47 -4.38 -1.69 1.07 1.73 2.41

Source: Capital IQ

Other Listings
US:AULSF
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista